Envoy MedicalCOCH
13F holders, Q2 2024 (June 30)20holders +3
8new positions
5sold out
$2.36avg. 13F price*
At the end of Q2 2024, 20 institutions reported holding Envoy Medical Inc. (COCH) in their 13F filings, up 3 from Q1 2024. 8 opened new positions and 5 sold out. The largest holders were Atlas Merchant Capital LLC ($1.3M), HighTower Advisors, LLC ($388K) and Vanguard Group Inc. ($274K).
- Company
- Envoy Medical Inc.
- CUSIP
- 29415V109
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 8 | $150K |
| Exits | 5 | $181K |
All 13F filers, Q1 2024 → Q2 2024: 93,263 shares bought and 104,690 shares sold, net −11,427 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 20 holders
| Atlas Merchant Capital LLC | 0.67% | Reduce -7.3% | 555,527 | $1.3M |
| HighTower Advisors, LLC | 0.00% | No change | 164,322 | $388K |
| Vanguard Group Inc. | 0.00% | Add +17.8% | 115,928 | $274K |
| Geode Capital Management, LLC | 0.00% | Reduce -3.4% | 86,959 | $205K |
| Polar Asset Management Partners Inc. | 0.01% | No change | 80,000 | $189K |
| Corient Private Wealth LP | 0.00% | New | 38,162 | $90K |
| Morgan Stanley | 0.00% | No change | 31,541 | $74K |
| State Street Corp. | 0.00% | Reduce -31.9% | 23,872 | $56K |
| Northern Trust Corp. | 0.00% | No change | 14,043 | $33K |
| Marquette Asset Management, LLC | 0.00% | New | 11,718 | $28K |
| WealthTrust Asset Management, LLC | 0.02% | No change | 11,316 | $27K |
| BlackRock Inc. | 0.00% | Add +1142.2% | 10,298 | $24K |
| UBS Group AG | 0.00% | New | 6,042 | $14K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 4,041 | $10K |
| Osaic Holdings, Inc. | 0.00% | New | 3,000 | $7K |
| Wells Fargo & Company | 0.00% | Add +976.1% | 2,744 | $6K |
| Royal Bank of Canada | 0.00% | No change | 1,698 | $4K |
| Steward Partners Investment Advisory, LLC | 0.00% | New | 726 | $2K |
| Bank of America Corp. | 0.00% | New | 57 | $135 |
| JPMorgan Chase & Co. | 0.00% | New | 21 | $50 |
"% of holder's portfolio" is COCH's weight in each manager's 13F, not the share of Envoy Medical Inc. the manager owns.